Maria Elisa Mancuso (M E Mancuso, Maria E Mancuso)

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 51

Top Topics

Patient Reported Outcomes

Top Venues

Haemophilia : the official journal of the World Federation of Hemophilia

Journal of clinical medicine

Expert review of hematology

Thrombosis and haemostasis

This page only lists publications with an associated author ORCID identifier.

Publications

Maria Elisa Mancuso, Paul Mclaughlin, Angela L Forsyth, Leonard A Valentino
Joint health and pain in the changing hemophilia treatment landscape. Expert review of hematology 17 (8) (2024)
Maria Elisa Mancuso, Paul Mclaughlin, Angela L Forsyth, Leonard A Valentino
Joint health and pain in the changing hemophilia treatment landscape. Expert review of hematology (2024)
Sanjay Ahuja, Tina T Biss, Monika Maas Enriquez, Maria Elisa Mancuso, MacGregor Steele, Gili Kenet
A post hoc analysis of PROTECT VIII kids assessing long-term efficacy and safety of damoctocog alfa pegol in adolescents with severe haemophilia A. European journal of haematology 112 (5) (2024)
Laura Banov, Silvia Linari, Luigi Ambroso, Enrico Ferri Grazzi, Samanta Gallo, Patrizio Pasqualetti, Maria Elisa Mancuso
Better Communication for Better Management of Persons with Hemophilia: Results from a Patients'-Clinicians' Project to Address the New Therapeutic Landscape. Journal of clinical medicine 13 (2) (2024)
Sanjay Ahuja, Tina T Biss, Monika Maas Enriquez, Maria Elisa Mancuso, MacGregor Steele, Gili Kenet
A post hoc analysis of PROTECT VIII kids assessing long-term efficacy and safety of damoctocog alfa pegol in adolescents with severe haemophilia A. European journal of haematology (2024)
Steven W Pipe, Peter Collins, Christophe Dhalluin, Gili Kenet, Christophe Schmitt, Muriel Buri, Victor Jimenez Yuste, Flora Peyvandi, Guy Aaron Young, Johannes Oldenburg, Maria Elisa Mancuso, Kaan Kavakli, Anna Kiialainen, Sonia Deb, Markus Niggli, Tiffany Chang, Michaela Lehle, Karin C J Fijnvandraat
Emicizumab prophylaxis in infants with hemophilia A (HAVEN 7): primary analysis of a phase 3b open-label trial. Blood 143 (14) (2024)
Maria Elisa Mancuso, Paul McLaughlin, Angela L Forsyth, Leonard A Valentino
Joint health and pain in the changing hemophilia treatment landscape. Expert review of hematology (2024)
Sanjay Ahuja, Tina T Biss, Monika Maas Enriquez, Maria Elisa Mancuso, MacGregor Steele, Gili Kenet
A post hoc analysis of PROTECT VIII kids assessing long-term efficacy and safety of damoctocog alfa pegol in adolescents with severe haemophilia A. European journal of haematology 112 (5) (2024)
Maria Elisa Mancuso, Stacy E Croteau, Robert Klamroth
Benefits and risks of non-factor therapies: Redefining haemophilia treatment goals in the era of new technologies. Haemophilia : the official journal of the World Federation of Hemophilia (2024)
Maria Elisa Mancuso, Chiara Biasoli, Renato Marino, Andrea Buzzi, Daniele Preti, Luigi Sannino, Rosaria Tempre, Sara Bendinelli, Elena Pompeo, Giacomo Siri, Giancarlo Castaman, null null
Physical Activity, Bleedings and Quality of Life in Subjects with Haemophilia A without Inhibitors-A Multicenter, Observational Italian Study with a Wearable Device. Journal of clinical medicine 13 (11) (2024)
Steven W Pipe, Peter Collins, Christophe Dhalluin, Gili Kenet, Christophe Schmitt, Muriel Buri, Victor Jimenez Yuste, Flora Peyvandi, Guy Aaron Young, Johannes Oldenburg, Maria Elisa Mancuso, Kaan Kavakli, Anna Kiialainen, Sonia Deb, Markus Niggli, Tiffany Chang, Michaela Lehle, Karin C J Fijnvandraat
Emicizumab prophylaxis in infants with hemophilia A (HAVEN 7): primary analysis of a phase 3b open-label trial. Blood 143 (14) (2024)
Massimo Morfini, Flora Peyvandi, Maria Elisa Mancuso, Emanuela Marchesini, Annarita Tagliaferri, Roberta Gualtierotti, Giancarlo Castaman, Berardino Pollio, Cristina Santoro, Luisa Banov, Mariasanta Napolitano, Paola Stefania Preti, Rita Carlotta Santoro, Antonio Coppola, Silvia Linari, Elena Santagostino, Francesco Bernardi
Pharmacokinetics of Efmoroctocog alfa by Two-Compartment Model Highlights Hemophilia A Patients with Biphasic Decay, Long Mean Residence Time, and Beta Half-Life. Journal of clinical medicine 13 (17) (2024)
Laura Banov, Silvia Linari, Luigi Ambroso, Enrico Ferri Grazzi, Samanta Gallo, Patrizio Pasqualetti, Maria Elisa Mancuso
Better Communication for Better Management of Persons with Hemophilia: Results from a Patients'-Clinicians' Project to Address the New Therapeutic Landscape. Journal of clinical medicine 13 (2) (2024)
Maria Elisa Mancuso, Chiara Biasoli, Renato Marino, Andrea Buzzi, Daniele Preti, Luigi Sannino, Rosaria Tempre, Sara Bendinelli, Elena Pompeo, Giacomo Siri, Giancarlo Castaman, null null
Physical Activity, Bleedings and Quality of Life in Subjects with Haemophilia A without Inhibitors-A Multicenter, Observational Italian Study with a Wearable Device. Journal of clinical medicine 13 (11) (2024)
Steven W Pipe, Peter Collins, Christophe Dhalluin, Gili Kenet, Christophe Schmitt, Muriel Buri, Victor Jimenez Yuste, Flora Peyvandi, Guy Aaron Young, Johannes Oldenburg, Maria Elisa Mancuso, Kaan Kavakli, Anna Kiialainen, Sonia Deb, Markus Niggli, Tiffany Chang, Michaela Lehle, Karin C J Fijnvandraat
Emicizumab prophylaxis in infants with hemophilia A (HAVEN 7): primary analysis of a phase 3b open-label trial. Blood 143 (14) (2024)
Maria Elisa Mancuso, Stacy E Croteau, Robert Klamroth
Benefits and risks of non-factor therapies: Redefining haemophilia treatment goals in the era of new technologies. Haemophilia : the official journal of the World Federation of Hemophilia (2024)
Maria Elisa Mancuso, Katharina Holstein, James S O'Donnell, Sébastien Lobet, Robert Klamroth, null null
Synovitis and joint health in patients with haemophilia: Statements from a European e-Delphi consensus study. Haemophilia : the official journal of the World Federation of Hemophilia (2023)
Maria Elisa Mancuso, Daniel Eriksson, Aletta Falk, Zalmai Hakimi, Piotr Wojciechowski, Marlena Wdowiak, Robert Klamroth
Efficacy of rFIXFc versus N9-GP Prophylaxis in Patients with Hemophilia B: Matching-Adjusted Indirect Comparison of B-LONG and PARADIGM 2 Trials. Journal of blood medicine 14 (2023)
Maria Elisa Mancuso, Katharina Holstein, James S O'Donnell, Sébastien Lobet, Robert Klamroth, null null
Synovitis and joint health in patients with haemophilia: Statements from a European e-Delphi consensus study. Haemophilia : the official journal of the World Federation of Hemophilia 29 (2) (2023)
Rolf Ljung, Anthony K C Chan, Heidi Glosli, Olubunmi Afonja, Bastian Becker, Despina Tseneklidou-Stoeter, Maria Elisa Mancuso, Sonata Saulyte-Trakymiene, Gili Kenet
BAY 81-8973 Efficacy and Safety in Previously Untreated and Minimally Treated Children with Severe Hemophilia A: The LEOPOLD Kids Trial. Thrombosis and haemostasis 123 (1) (2023)
Maria Elisa Mancuso, Katharina Holstein, James S O'Donnell, Sébastien Lobet, Robert Klamroth, null null
Synovitis and joint health in patients with haemophilia: Statements from a European e-Delphi consensus study. Haemophilia : the official journal of the World Federation of Hemophilia 29 (2) (2023)
Steven W Pipe, Peter W Collins, Christophe Dhalluin, Gili Kenet, Christophe Schmitt, Muriel Buri, Victor Jimenez Yuste, Flora Peyvandi, Guy Aaron Young, Johannes Oldenburg, Maria Elisa Mancuso, Kaan Kavakli, Anna Kiialainen, Sonia Deb, Markus Niggli, Tiffany Chang, Michaela Lehle, Karin C J Fijnvandraat
Emicizumab prophylaxis in infants with hemophilia A (HAVEN 7): primary analysis of a phase 3b, open-label trial. Blood (2023)
Birgit M Reipert, Christoph J Hofbauer, Bagirath Gangadharan, Verena Berg, Elizabeth Donnachie, Shannon L Meeks, Maria Elisa Mancuso, Joel Bowen, Deborah L Brown
Qualification of Hemophilia Treatment Centers to Enable Multi-Center Studies of Gene Expression Signatures in Blood Cells from Pediatric Patients. Journal of clinical medicine 12 (5) (2023)
Steven W Pipe, Peter W Collins, Christophe Dhalluin, Gili Kenet, Christophe Schmitt, Muriel Buri, Victor Jimenez Yuste, Flora Peyvandi, Guy Aaron Young, Johannes Oldenburg, Maria Elisa Mancuso, Kaan Kavakli, Anna Kiialainen, Sonia Deb, Markus Niggli, Tiffany Chang, Michaela Lehle, Karin C J Fijnvandraat
Emicizumab prophylaxis in infants with hemophilia A (HAVEN 7): primary analysis of a phase 3b, open-label trial. Blood (2023)
Rolf Ljung, Anthony K C Chan, Heidi Glosli, Olubunmi Afonja, Bastian Becker, Despina Tseneklidou-Stoeter, Maria Elisa Mancuso, Sonata Saulyte-Trakymiene, Gili Kenet
BAY 81-8973 Efficacy and Safety in Previously Untreated and Minimally Treated Children with Severe Hemophilia A: The LEOPOLD Kids Trial. Thrombosis and haemostasis 123 (1) (2023)
Rolf Ljung, Anthony K C Chan, Heidi Glosli, Olubunmi Afonja, Bastian Becker, Despina Tseneklidou-Stoeter, Maria Elisa Mancuso, Sonata Saulyte-Trakymiene, Gili Kenet
BAY 81-8973 Efficacy and Safety in Previously Untreated and Minimally Treated Children with Severe Hemophilia A: The LEOPOLD Kids Trial. Thrombosis and haemostasis 123 (1) (2023)
Maria Elisa Mancuso, Katharina Holstein, James S O'Donnell, Sébastien Lobet, Robert Klamroth, null null
Synovitis and joint health in patients with haemophilia: Statements from a European e-Delphi consensus study. Haemophilia : the official journal of the World Federation of Hemophilia 29 (2) (2023)
Birgit M Reipert, Christoph J Hofbauer, Bagirath Gangadharan, Verena Berg, Elizabeth Donnachie, Shannon L Meeks, Maria Elisa Mancuso, Joel Bowen, Deborah L Brown
Qualification of Hemophilia Treatment Centers to Enable Multi-Center Studies of Gene Expression Signatures in Blood Cells from Pediatric Patients. Journal of clinical medicine 12 (5) (2023)
Helmut Paul, Verena Berg, Bagirath M Gangadharan, Joel Bowen, Petra LeBeau, Jan Blatny, Christoph Male, Vlad Calin Radulescu, Rosa Diaz, Maria Elisa Mancuso, Deborah L Brown, Birgit M Reipert
Prospective hemophilia inhibitor PUP study reveals distinct antibody signatures during FVIII inhibitor eradication. Blood advances (2022)
Maria Elisa Mancuso, Giancarlo Castaman, Michal Pochopien, Samuel Aballéa, Aleksandra Drzewiecka, Zalmai Hakimi, Jameel Nazir, Francis Fatoye
Cost-minimization analysis of recombinant factor VIII Fc versus emicizumab for treating patients with hemophilia A without inhibitors in Europe. Journal of medical economics 25 (1) (2022)
Johannes Oldenburg, Steven W Pipe, Maria Elisa Mancuso, Robert Klamroth, Abel Hassoun, Martin Olivieri, Georg Goldmann, Gili Kenet, Wolfgang Miesbach, Jolana Schmiedl, Inga Hegemann
Clinical experience of switching patients with severe hemophilia to rVIII-SingleChain or rIX-FP. Current medical research and opinion (2022)
Maria Elisa Mancuso, Sheila J M Ingham, Marc Kunze
Befovacimab, an anti-tissue factor pathway inhibitor antibody: Early termination of the multiple-dose, dose-escalating Phase 2 study due to thrombosis. Haemophilia : the official journal of the World Federation of Hemophilia 28 (5) (2022)
Miguel A Escobar, Maria Elisa Mancuso, Cedric Hermans, Cindy Leissinger, Wilfried Seifert, Yanyan Li, William McKeand, Johannes Oldenburg
IDELVION: A Comprehensive Review of Clinical Trial and Real-World Data. Journal of clinical medicine 11 (4) (2022)
Giancarlo Castaman, Christian Carulli, Raimondo De Cristofaro, Marco Follino, Angelo Lupi, Maria Elisa Mancuso, Maria Francesca Mansueto, Angelo Claudio Molinari, Pietro Pasquetti, Cristina Santoro, Rita Carlotta Santoro, Sergio Siragusa, Luigi Piero Solimeno, Armando Tripodi, Ezio Zanon, Giovanni Di Minno
Laying the foundations for gene therapy in Italy for patients with haemophilia A: A Delphi consensus study. Haemophilia : the official journal of the World Federation of Hemophilia (2022)
Jan Astermark, Cihan Ay, Manuela Carvalho, Roseline D'Oiron, Philippe De Moerloose, Gerard Dolan, Andreas Greinacher, Cedric Hermans, Pål Andre Holme, Olga Katsarou, Gili Kenet, Robert Klamroth, Maria Elisa Mancuso, Natascha Marquardt, Ramiro Núñez, Ingrid Pabinger, Robert Tait, Paul van der Valk
New Inhibitors in the Ageing Population: A Retrospective, Observational, Cohort Study of New Inhibitors in Older People with Hemophilia. Thrombosis and haemostasis (2021)
Maria Elisa Mancuso, Tina Biss, Kathelijn Fischer, Monika Maas Enriquez, MacGregor Steele, Maria Wang, Despina Tseneklidou-Stoeter, Sanjay Ahuja, Gili Kenet
PROTECT VIII kids extension study: Long-term safety and efficacy of BAY 94-9027 (damoctocog alfa pegol) in children with severe haemophilia A. Haemophilia : the official journal of the World Federation of Hemophilia 27 (3) (2021)
Giovanni Di Minno, Antonio Coppola, Maurizio Margaglione, Angiola Rocino, Maria Elisa Mancuso, Annarita Tagliaferri, Silvia Linari, Ezio Zanon, Cristina Santoro, Chiara Biasoli, Giancarlo Castaman, Elena Santagostino, Pier Mannuccio Mannucci, null null
Predictors of inhibitor eradication by primary immune tolerance induction in severe haemophilia A with high responding inhibitors. Haemophilia : the official journal of the World Federation of Hemophilia (2021)
Ezio Lanza, Maria Elisa Mancuso, Gaia Messana, Paola Ferrazzi, Costanza Lisi, Pierpaolo Di Micco, Stefano Barco, Luca Balzarini, Corrado Lodigiani
Compromised Lung Volume and Hemostatic Abnormalities in COVID-19 Pneumonia: Results from an Observational Study on 510 Consecutive Patients. Journal of clinical medicine 10 (13) (2021)
Manuel Carcao, Maria Elisa Mancuso, Guy Aaron Young, Victor Jimenez Yuste
Key questions in the new hemophilia era: update on concomitant use of FVIII and emicizumab in hemophilia A patients with inhibitors. Expert review of hematology 14 (2) (2021)
Mark T Reding, Ingrid Pabinger-Fasching, Pal Andre Holme, Lone Poulsen, Claude G Negrier, Pavani Chalasani, Monika Maas Enriquez, Maria Wang, Karina Meijer, Maria Elisa Mancuso, Shadan Lalezari
Confirmed long-term safety and efficacy of prophylactic treatment with BAY 94-9027 in severe haemophilia A: final results of the PROTECT VIII extension study. Haemophilia : the official journal of the World Federation of Hemophilia 27 (3) (2021)
Maria Elisa Mancuso, Mark T Reding, Claude Negrier, Bryce A Kerlin, Savita Rangarajan, Mindy L Simpson
Decreased Bleeding Rates in Patients with Hemophilia A Switching from Standard-Half-Life FVIII to BAY 94-9027 Prophylaxis. Thrombosis and haemostasis 121 (8) (2020)
Maria Elisa Mancuso, Silvia Linari, Elena Santagostino, Dario Bartolozzi, Roberta D'Ambrosio, Marta Borghi, Pietro Lampertico, Flora Peyvandi, Giancarlo Castaman, Alessio Aghemo
High rate of sustained virological response with direct-acting antivirals in haemophiliacs with HCV infection: A multicenter study. Liver international : official journal of the International Association for the Study of the Liver 40 (5) (2020)
David Lillicrap, Karin Fijnvandraat, Guy Young, Maria Elisa Mancuso
Patients with hemophilia A and inhibitors: prevention and evolving treatment paradigms. Expert review of hematology 13 (4) (2020)
H Marijke van den Berg, Maria Elisa Mancuso, Christoph Königs, Roseline D'Oiron, Helen Platokouki, Torben Stamm Mikkelsen, Jayashree Motwani, Beatrice Nolan, Elena Santagostino, null null
ITI Treatment is not First-Choice Treatment in Children with Hemophilia A and Low-Responding Inhibitors: Evidence from a PedNet Study. Thrombosis and haemostasis 120 (8) (2020)
Mark T Reding, Ingrid Pabinger-Fasching, Shadan Lalezari, Elena Santagostino, Maria Elisa Mancuso
Target joint resolution in patients with haemophilia A receiving long-term prophylaxis with BAY 94-9027. Haemophilia : the official journal of the World Federation of Hemophilia 26 (4) (2020)
Miguel Escobar, Elena Santagostino, Maria Elisa Mancuso, Michiel Coppens, Vinod Balasa, Jason A Taylor, Alfonso Iorio, Claude Negrier
Switching patients in the age of long-acting recombinant products? Expert review of hematology 12 (sup1) (2020)
Lorraine Cafuir, Rebecca Kruse-Jarres, Maria Elisa Mancuso, Christine L Kempton
Emicizumab for hemophilia A without inhibitors. Expert review of hematology 12 (7) (2019)
Jayson M Stoffman, Nadine G Andersson, Brian R Branchford, K Batt, Roseline d'Oiron, C Escuriola Ettingshausen, D P Hart, V Jiménez Yuste, Kaan Kavakli, Maria Elisa Mancuso, K Nogami, C Ramírez, R Wu
Common themes and challenges in hemophilia care: a multinational perspective. Hematology (Amsterdam, Netherlands) 24 (1) (2018)
Nadine G Andersson, Günter Auerswald, Chris Barnes, Manuel D Carcao, Amy L Dunn, Karin Fijnvandraat, Marianne Hoffmann, Kaan Kavakli, Gili Kenet, Rainer Kobelt, Karin Kurnik, Ri Liesner, Anne Mäkipernaa, Marilyn J Manco-Johnson, Maria Elisa Mancuso, Angelo C Molinari, Beatrice Nolan, Rosario Perez Garrido, Pia Petrini, Helen E Platokouki, Amy D Shapiro, Runhui Wu, Rolf Ljung
Intracranial haemorrhage in children and adolescents with severe haemophilia A or B - the impact of prophylactic treatment. British journal of haematology 179 (2) (2017)
Maria Elisa Mancuso, Elena Santagostino
Platelets: much more than bricks in a breached wall. British journal of haematology 178 (2) (2017)
Marcin M Gorski, Kevin Blighe, Luca A Lotta, Emanuela Pappalardo, Isabella Garagiola, Illaria Mancini, Maria Elisa Mancuso, Maria Rosaria Fasulo, Elena Santagostino, Flora Peyvandi
Whole-exome sequencing to identify genetic risk variants underlying inhibitor development in severe hemophilia A patients. Blood 127 (23) (2016)